- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies ; day:1 ; month:4 ; year:2022 ; pages:1-10
Current oncology reports ; (1.4.2022), 1-10
- Urheber
-
Lundberg, Kristina Ihrmark
Treis, Diana
Johnsen, John Inge
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-022-01270-8
- URN
-
urn:nbn:de:101:1-2022062020354200673858
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lundberg, Kristina Ihrmark
- Treis, Diana
- Johnsen, John Inge
- SpringerLink (Online service)
Ähnliche Objekte (12)
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer
Transcription factors in fibroblast plasticity and CAF heterogeneity
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer
Transcription factors in fibroblast plasticity and CAF heterogeneity
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer